|
|
|
|
| LEADER |
01579nam a2200337 u 4500 |
| 001 |
EB001999899 |
| 003 |
EBX01000000000000001162800 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
210907 r ||| eng |
| 100 |
1 |
|
|a Li, Ke Xin
|
| 245 |
0 |
0 |
|a Transcatheter mitral valve repair device for the treatment of tricuspid or tricuspid and mitral regurgitation
|h Elektronische Ressource
|b a review of clinical effectiveness and cost-effectiveness
|c Ke Xin Li, Mary-Doug Wright
|
| 250 |
|
|
|a Version: 1.0
|
| 260 |
|
|
|a Ottawa (ON)
|b CADTH
|c 2020, June 02, 2020
|
| 300 |
|
|
|a 1 PDF file (24 pages)
|b illustrations
|
| 653 |
|
|
|a Canada
|
| 653 |
|
|
|a Heart Valve Prosthesis
|
| 653 |
|
|
|a Cost-Benefit Analysis
|
| 653 |
|
|
|a Tricuspid Valve Insufficiency / surgery
|
| 653 |
|
|
|a Treatment Outcome
|
| 653 |
|
|
|a Mitral Valve Insufficiency / surgery
|
| 653 |
|
|
|a Heart Valve Prosthesis Implantation / instrumentation
|
| 700 |
1 |
|
|a Wright, Mary-Doug
|e [author]
|
| 710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|b Rapid Response Service
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a CADTH rapid response report: summary with critical appraisal
|
| 856 |
4 |
0 |
|u http://www.ncbi.nlm.nih.gov/books/NBK564102
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 580
|
| 082 |
0 |
|
|a 700
|
| 520 |
|
|
|a The purpose of this report is to summarize the clinical effectiveness and cost-effectiveness of the transcatheter mitral valve repair device for TR with or without mitral regurgitation
|